Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 18, 2025, Coherus BioSciences (CHRS) has a market cap of $0.13 billion USD. According to our data, Coherus BioSciences is ranked No.7366 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 18, 2025 | $0.13 B |
-18.84%
|
| Dec 31, 2024 | $0.16 B |
-58.56%
|
| Dec 29, 2023 | $0.39 B |
-57.95%
|
| Dec 30, 2022 | $0.92 B |
-50.38%
|
| Dec 31, 2021 | $1.85 B |
-8.17%
|
| Dec 31, 2020 | $2.01 B |
-3.47%
|
| Dec 31, 2019 | $2.09 B |
98.95%
|
| Dec 31, 2018 | $1.05 B |
2.84%
|
| Dec 29, 2017 | $1.02 B |
-68.74%
|
| Dec 30, 2016 | $3.26 B |
22.60%
|
| Dec 31, 2015 | $2.66 B |
40.69%
|
| Dec 31, 2014 | $1.89 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Hikma Pharmaceuticals
HIK.L
|
$5.52 B |
0.000 M
|
UK
|
| Market Cap | = | CHRS Stock Price | * | CHRS Shares Outstanding |
| = | $1.12 | * | 0.12 B | |
| = | $0.13 B |